Systolic left ventricular apical bulging after biventricular pacing mimicking takotsubo cardiomyopathy

Takayuki Nagai1, Hideki Okayama2, Katsuji Inoue1

  • 1Division of Cardiology, Department of Integrated Medicine and Informatics, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.

Insights

Nonresponsiveness to cardiac resynchronization therapy (CRT) can be overcome. A patient with heart failure and left bundle branch block had their CRT lead repositioned, restoring heart function and reversing remodeling.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Nonresponsiveness to cardiac resynchronization therapy (CRT) is a significant challenge in managing heart failure patients with conduction disturbances.
  • Left bundle branch block (LBBB) is a common indication for CRT, but some patients do not respond adequately.

Purpose of the Study:

  • To describe a case of successful lead repositioning in a patient with refractory heart failure and LBBB who was initially nonresponsive to CRT.
  • To highlight the importance of optimal lead placement for CRT efficacy.

Main Methods:

  • Surgical implantation of an epicardial left ventricular (LV) lead guided by thoracoscopy.
  • Management of unexpected apical lead placement and subsequent lead re-implantation using an endovascular approach via a cardiac vein branch.
  • Echocardiographic assessment of left ventricular (LV) function and remodeling.

Main Results:

  • Initial LV lead placement on the apical side resulted in LV motion mimicking takotsubo cardiomyopathy and lack of CRT response.
  • Successful re-implantation of the LV lead into a lateral cardiac vein branch using an endovascular technique.
  • Restored LV contractility and reversal of LV remodeling post-lead repositioning.

Conclusions:

  • Optimal lead placement is critical for achieving successful cardiac resynchronization therapy.
  • Endovascular lead revision can be an effective strategy for managing CRT nonresponse due to lead malposition.
  • This case demonstrates a viable solution for refractory heart failure patients with LBBB and CRT lead issues.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
824
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
640
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
727
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
994
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
892